Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
78,23 CHF | +0,32 % | +2,55 % | +1,40 % |
15.01. | Alcon strebt Fusionen und Übernahmen an | CI |
15.01. | Alcon Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 04:30 PM |
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz | Nettogewinn | Umsatzrendite | ROE | ROA | Verschuldungsgrad (Verbindlichkeiten / EBITDA) | |
---|---|---|---|---|---|---|---|
9 455 000 000,00 | +10,30% | +19,56% | 4.83x | 3.31x | 1.55x | ||
26 409 109 816,97 | +9,01% | +16,45% | 7.65x | 4.87x | 0.82x | ||
3 895 400 000,00 | +10,07% | +24,93% | 9.47x | 6.18x | 1.84x | ||
669 765 000,00 | -9,44% | +2,06% | 4.01x | - | -4.14x | ||
237 935 688,26 | +38,37% | +49,26% | 15.58x | 12.53x | -1.08x | ||
241 013 696,75 | +18,58% | +21,59% | 25.74x | 17.34x | - | ||
102 553 514,59 | +21,04% | +26,73% | 10.33x | 8.99x | - | ||
207 698 173,81 | +24,39% | +29,18% | 20.27x | 14.14x | -1.7x | ||
746 394 639,98 | +3,91% | +7,70% | 6x | 4.95x | 1.39x | ||
124 874 002,02 | - | +32,14% | 35.8x | 21.7x | -0.6x | ||
86 901 221,17 | +16,39% | +27,35% | 24.7x | - | - | ||
73 343 580,80 | +12,58% | +13,85% | 9.97x | 6.02x | 0.47x | ||
134 406 656,27 | +12,43% | +13,79% | 8.8x | 6.8x | -1.8x | ||
83 907 534,06 | +12,17% | +16,26% | 7.58x | 5.13x | 1.18x | ||
23 323 320,09 | - | +27,83% | 15.87x | - | - | ||
208 105 555,95 | +6,06% | +6,33% | 13.4x | 4.6x | - | ||
252 791 010,00 | -0,49% | +5,86% | - | - | 1.88x | ||
Durchschnitt | 2.526.619.024,16 | +12,36 % | +20,05 % | 13,75x | 8,97x | -0,02x | |
Gewichteter Durchschnitt nach Marktkapitalisierung | 18.817.752.789,6 | +9,67 % | +18,31 % | 7,56x | 4,95x | 0,97x |
- Börse
- Aktien
- A2PDXE Aktie
- Sektor Alcon Inc.
- Finanzielle Vergleiche
MarketScreener is also available in this country: United States.
Switch edition